$5.58
-0.03-0.53%
At close: -
$5.58
0.000.00%
After Hours: Jan 24, 4:00 PM EDT
Lexeo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexeo Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.89 | $-0.68 | -30.9 % |
Q2 | 2024-08-12 | $-0.64 | $-0.79 | 19.0 % |
Q1 | 2024-05-09 | $-0.77 | $-0.77 | 0.00 % |
Q4 | 2024-03-11 | $-0.86 | $-0.73 | -17.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Lexeo Therapeutics (LXEO) is scheduled to report earnings on February 7, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.89, which missed the estimate of $-0.68.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.